Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis

Table 1 Clinical characteristics of patients

Patient	Sex	Age (years)	Diagnosis	Clinical pattern	RF	ACPA	Time of evolution (years)	Treatment	CC dose (mg/day)
1	F	46	RA	Polyarticular	Pos	Pos	11	Anti-TNF + MTX + PRED	5–10
2	F	55	RA	Polyarticular	Neg	Neg	9	MTX	0
3	F	77	RA	Polyarticular	Pos	Pos	8	MTX + OH CLQ + DEFL	6
4	F	51	RA	Polyarticular	Neg	Neg	8	MTX	0
5	M	33	RA	Polyarticular	Neg	ND	15	Anti-TNF + MTX	0
6	M	25	RA	Polyarticular	Neg	Neg	0	None	0
7	M	17	RA	Polyarticular	Neg	Neg	14	Anti-TNF + MTX	0
8	F	53	RA	Polyarticular	Pos	Pos	16	MTX + PRED	7.5
9	F	62	RA	Polyarticular	Pos	Pos	7	Anti-TNF + MTX + PRED	5
10	M	70	RA	Polyarticular	Neg	ND	7	PRED	5
11	F	98	RA	Polyarticular	Pos	Pos	11	Anti-IL-6 + PRED	5
12	M	71	RA	Polyarticular	Pos	Pos	8	PRED	5
13	F	47	PsA	Polyarticular	Neg	ND	16	MTX + NSAID	0
14	M	52	PsA	Polyarticular	Neg	ND	12	MTX + DEFL	7.5
15	M	53	PsA	Polyarticular	Neg	Neg	13	MTX + DEFL	15
16	M	53	PsA	Polyarticular	Neg	Neg	13	MTX + DEFL	15
17	M	58	PsA	Oligoarticular	Neg	Neg	0	None	0
18	F	39	PsA	Polyarticular	Neg	ND	5	Anti-IL-17	0
19	F	31	PsA	Polyarticular	Neg	ND	7	PRED	5
20	M	46	PsA	Oligoarticular	Neg	Neg	6	PRED	7.5
21	F	32	PsA	Polyarticular	Neg	ND	8	PRED	5
22	M	25	PsA	Oligoarticular	Neg	Neg	0	None	0
23	M	55	PsA	Oligoarticular	Neg	ND	6	Anti-TNF + MTX	0
24	M	54	PsA	Polyarticular	Neg	Neg	7	Anti-TNF + MTX	0
25	F	65	PsA	Oligoarticular	Neg	Neg	40	NSAID	0

ACPA anti-citrullinated peptide antibodies, CC corticosteroid, DEFL deflazacort, F female, IL interleukin, M male, MTX methotrexate, ND not determined, Neg negative, NSAID nonsteroidal antiinflammatory drug, PsA psoriatic arthritis, Pos positive, PRED prednisone, OH CLQ hydroxycloroquine, RA rheumatoid arthritis, RF rheumatoid factor, TNF tumor necrosis factor

ISSN: 1478-6362